Yes, divalproex commonly causes weight gain. The average gain is around 6 kilograms (about 13 pounds), with weight typically increasing steadily over the first several months of treatment and peaking around the six-month mark. Women tend to gain more weight than men, and the effect goes beyond simple appetite changes: divalproex alters how your body processes insulin, stores fat, and regulates hunger signals.
How Much Weight Gain to Expect
Across studies of people taking standard doses, the average weight gain is approximately 6 kg (13 lbs). That number represents an average, so some people gain considerably more while others see little change. Weight tends to climb most noticeably during the first six months, then plateau. If you haven’t gained significant weight by that point, you’re less likely to see a major increase later on.
Women consistently gain more weight than men on divalproex. In one study of 106 patients, both genders experienced statistically significant weight gain, but women gained weight more frequently and to a greater degree. About 26% of women in the study reported strong carbohydrate cravings, compared with 14% of men. Women also reported higher levels of distress about the weight change, with roughly 23% attempting to diet compared to 7% of men.
Why Divalproex Changes Your Metabolism
The weight gain isn’t just about eating more, though increased appetite plays a role. Divalproex affects your body through several overlapping pathways. It increases signaling from a brain chemical called GABA in the hypothalamus, the region that controls hunger and thirst. This can make you feel hungrier and thirstier than usual, particularly for carbohydrate-rich foods.
At the same time, divalproex pushes your body toward insulin resistance. Even in lean patients who haven’t gained weight, the drug has been linked to higher fasting insulin levels. A study comparing people with bipolar disorder on divalproex to those not taking the medication found that divalproex users had significantly higher insulin, BMI, triglycerides, and fasting blood sugar, along with lower levels of HDL (the protective form of cholesterol). The drug also appears to interfere with how your body breaks down fatty acids for energy, and it modifies genes involved in fat cell signaling and energy balance.
These metabolic shifts mean the weight gain is partly driven by changes in how your body handles calories, not only by how many calories you consume. That’s one reason why the weight can be stubborn to lose through diet alone.
Metabolic Syndrome: The Bigger Picture
Weight gain is the most visible effect, but it’s part of a broader metabolic shift that can develop during long-term divalproex use. Metabolic syndrome is a cluster of conditions that tend to occur together: excess abdominal fat, high blood pressure, elevated blood sugar, high triglycerides, and low HDL cholesterol. Having three or more of these raises your risk of heart disease and type 2 diabetes significantly.
Divalproex has been associated with all of these components. Research shows increased waist circumference, insulin resistance, and unfavorable cholesterol profiles in people on the drug, even when controlling for other medications. This means that even if your weight gain seems modest, the metabolic changes underneath may still be worth monitoring through routine blood work.
How It Compares to Other Mood Stabilizers
Among mood stabilizers used alone, divalproex carries a moderate weight gain risk. In a pooled analysis of short-term trials, patients on a single mood stabilizer (including divalproex and lithium) gained an average of 1.2 kg over roughly 12 weeks. Patients on two mood stabilizers gained about 2.1 kg. The biggest jumps came when an antipsychotic was added on top of a mood stabilizer, pushing the average to 5.5 kg in the same timeframe.
Lamotrigine is generally considered the most weight-neutral mood stabilizer. Lithium causes weight gain as well, though the pattern and amount can differ between individuals. If weight gain is a primary concern, these comparisons are worth discussing when choosing or adjusting a treatment plan.
Managing the Weight Gain
Starting healthy habits early, ideally when you first begin divalproex rather than after the weight has accumulated, makes a meaningful difference. Behavioral and educational approaches have shown positive results in clinical trials, and guidelines recommend them for anyone starting a medication known to affect weight.
For people who find lifestyle changes alone insufficient, metformin has the strongest evidence as an add-on option. In a well-designed trial, metformin produced about 3 kg of weight loss compared to placebo over 12 to 16 weeks. Combining metformin with structured diet and exercise was even more effective, resulting in roughly 4.7 kg of weight loss. Lifestyle changes alone, by comparison, led to about 1.4 kg of loss. So the combination approach outperformed either strategy on its own.
Because divalproex drives weight gain partly through insulin resistance rather than appetite alone, the carbohydrate cravings many people experience are worth paying specific attention to. Recognizing those cravings as a drug effect rather than a willpower failure can help you respond with practical strategies like keeping high-protein snacks accessible or adjusting meal timing to stay ahead of hunger spikes.
Who Is Most at Risk
Women face a higher risk of clinically significant weight gain on divalproex, likely related to differences in the hormone leptin. Women on divalproex who gained weight showed significantly higher leptin levels than men, suggesting a form of leptin resistance where the body produces the “fullness” hormone but stops responding to it properly. This may partly explain why women report stronger carbohydrate cravings and find the weight harder to control.
Higher baseline weight before starting treatment, higher doses, and longer duration of use are all associated with greater weight gain. People already showing early signs of metabolic changes, such as elevated fasting blood sugar or borderline cholesterol, may be more vulnerable to the full metabolic syndrome picture developing over time. Regular monitoring of weight, waist circumference, and basic metabolic labs gives you and your provider the information needed to intervene early if the numbers start trending in the wrong direction.